Powered By

×

Dr Lalchandani Labs

DLCL

Price

Micro Cap

₹6 Cr.

New to Zerodha? Sign-up for free.

Dr Lalchandani Labs Limited is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through their integrated network, it offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

Dr Lalchandani Labs Limited is a provider of diagnostic and related healthcare tests and services i… More

Dr Lalchandani Labs Limited is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through their integrated network, it offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Less

Low

9.80

52W Range

High

28.90

PE

8.98

Sector PE

39.09

P/B

--

Div.Yield

--

ROE

6.47%

EBIDTA

--

ROCE

-1.9

EPS

--

New to Zerodha? Sign-up for free.

Share Price
Financials
Revenue mix
Shareholdings
Peers
Forensics

5D
1M
6M
YTD
1Y
5Y
MAX

This data is currently unavailable for this company.

Summary
Profit & Loss
Balance sheet
Cashflow

View Detailed Summary

This data is currently unavailable for this company.

Yearly | Quarterly

(In Cr.)

(In Cr.)
This data is currently unavailable for this company.

Financial Ratio's

(In %)

Detailed P&L Report

(In Cr.)

Detailed Balance Sheet

Financial Year (In Cr.)

Detailed Cash Flow

Product wise
Location wise

DLCL
Revenue Mix

Latest

|

Historic

This data is currently unavailable for this company.

DLCL
Revenue Mix

Latest

|

Historic

This data is currently unavailable for this company.

Shareholdings

Holders

Detailed Shareholdings

This data is currently unavailable for this company.

Peers

Forensics

View Detailed Forensics

Recent events

News
Corporate Actions

This data is currently unavailable for this company.

Events:

Quarterly Results

Announcement Date

Oct 14, 2024

Announcement Date

Sep 07, 2024

Quarterly Results

Announcement Date

May 30, 2024

Quarterly Results

Announcement Date

Nov 14, 2023

Announcement Date

Sep 08, 2023

Quarterly Results

Announcement Date

May 30, 2023

Quarterly Results

Announcement Date

Nov 14, 2022

Reg. 34 (1) Annual Report.

Announcement Date

Sep 08, 2022

Quarterly Results

Announcement Date

May 30, 2022

Quarterly Results

Announcement Date

Nov 12, 2021

Quarterly Results

Announcement Date

Jun 30, 2021

Quarterly Results

Announcement Date

Nov 13, 2020

Quarterly Results

Announcement Date

Sep 04, 2020

Quarterly Results

Announcement Date

Jul 28, 2020

Quarterly Results

Announcement Date

Jun 30, 2020

More Micro Cap Ideas

See similar 'Micro' cap companies with recent activity

Promoter Buying

Companies where the promoters are bullish

Detailed List

Capex

Companies investing on expansion

Detailed List

Superstar Investor

Companies where well known investors have invested

Detailed List

Popular questions

Business
Financials
Share Price
Shareholdings

What does Dr Lalchandani Labs do?

Dr Lalchandani Labs Limited is a leading provider of diagnostic and healthcare tests in Delhi/NCR, offering a wide range of services for patient care and disease prevention.

Who are the competitors of Dr Lalchandani Labs?

Dr Lalchandani Labs major competitors are Looks Health Service, Dolphin Medical Serv, DhanvantriJeevan Rek, Clinitech Laboratory, Broach Lifecare Hosp, Gian Life Care, Global Longlife Hosp. Market Cap of Dr Lalchandani Labs is ₹5 Crs. While the median market cap of its peers are ₹10 Crs.

Is Dr Lalchandani Labs financially stable compared to its competitors?

Dr Lalchandani Labs seems to be less financially stable compared to its competitors. Altman Z score of Dr Lalchandani Labs is 1.59 and is ranked 4 out of its 8 competitors.

Does Dr Lalchandani Labs pay decent dividends?

The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Dr Lalchandani Labs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

How has Dr Lalchandani Labs allocated its funds?

Companies resources are majorly tied in miscellaneous assets

How strong is Dr Lalchandani Labs balance sheet?

Dr Lalchandani Labs balance sheet is weak and might have solvency issues

Is the profitablity of Dr Lalchandani Labs improving?

Yes, profit is increasing. The profit of Dr Lalchandani Labs is ₹0.86 Crs for TTM, ₹0.62 Crs for Mar 2024 and -₹1.56 Crs for Mar 2023.

Is the debt of Dr Lalchandani Labs increasing or decreasing?

The debt of Dr Lalchandani Labs is decreasing. Latest debt of Dr Lalchandani Labs is ₹0.81 Crs as of Sep-24. This is less than Mar-24 when it was ₹1.28 Crs.

Is Dr Lalchandani Labs stock expensive?

Dr Lalchandani Labs is not expensive. Latest PE of Dr Lalchandani Labs is 8.7, while 3 year average PE is 10.74. Also latest EV/EBITDA of Dr Lalchandani Labs is 0 while 3yr average is 13.75.

Has the share price of Dr Lalchandani Labs grown faster than its competition?

Dr Lalchandani Labs has given lower returns compared to its competitors. Dr Lalchandani Labs has grown at ~-33.93% over the last 2yrs while peers have grown at a median rate of -1.77%

Is the promoter bullish about Dr Lalchandani Labs?

Promoters seem not to be bullish about the company and have been selling shares in the open market. Latest quarter promoter holding in Dr Lalchandani Labs is 48.32% and last quarter promoter holding is 57.18%

Are mutual funds buying/selling Dr Lalchandani Labs?

There is Insufficient data to gauge this.